![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3911|5|3|234-244
ISSN: 1574-8863
Source: Current Drug Safety, Vol.5, Iss.3, 2010-07, pp. : 234-244
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Tunis Sandra L. Minshall Michael E. St. Charles Meaghan Pandya Bhavik J. Baran Robert W.
Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
Annals of Medicine, Vol. 45, Iss. 8, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kanazawa I. Yamaguchi T. Yano S. Yamamoto M. Yamauchi M. Kurioka S. Sugimoto T.
Osteoporosis International, Vol. 21, Iss. 12, 2010-12 ,pp. :